pharmacotherapy

DDAVP/Desmopressin for Clozapine induced sialorrhea???

Dear List:   Has anyone heard of using desmopressin (DDAVP) for clozapine induced sialorrhea?  I have a psychiatrist that is insisting that this is commonly used and done all the time.  I found no literature on the topic.  ...

Metabolic syndrome monitoring -baseline

Wondering how others that are monitoring metabolic syndrome define "baseline" for patients admitted to your facility already on a SGA. Do you r etrospectively try to find the weight prior to starting the medication or do you just ...

Are Extrapyramidal Symptoms Less Recognized? Case Report of Modern Practitioners’ Unfamiliarity with First Generation Antipsychotics

Tara L. Purvis, PharmD, BCPP
Veteran Affairs Sierra Nevada Healthcare System
Reno, Nevada 89502

The author received no support of any kind in writing this manuscript and has no potential conflicts of interest to disclose.  

The case report was published in Pharmacotherapy February 2011 and presented as a clinical pearl at the CPNP Annual Meeting. In that presentation however. emphasis was placed on the pharmacokinetics of fluphenazine decanoate.

A case is presented where initial suspicion of lithium toxicity was truly drug-induced Parkinsonism and tardive dyskinesia. The mistaken diagnosis underscores the need to improve training for movement disorder assessment.

Pharmacotherapy and Academic Achievement Among Children with Attention-Deficit/Hyperactivity Disorder

Journal of Child and Adolescent Psychopharmacology Dec 2011, Vol. 21, No. 6: 597-603. (Source: Journal of Child and Adolescent Psychopharmacology)

2012-2013 APNA Endorsed CPNP Psychiatric Pharmacotherapy Review Course

In cooperation with the American Psychiatric Nurses Association (APNA), the College of Psychiatric and Neurologic Pharmacists (CPNP) is pleased to offer the APNA endorsed CPNP Psychiatric Pharmacotherapy Review Course at CPNP member rates. This course is structured to provide knowledge- based education as defined in Accreditation Council for Pharmacy Education (ACPE) guidelines. The course examinations must be submitted by December 31, 2013.

APNA members can access this Accreditation Council for Pharmacy Education (ACPE) approved distance education course at CPNP member prices. Both a for-credit and no-credit (resource only) purchase option is being provided at a cost of $320 and $150 respectively. Non members of APNA can purchase the product for $480 (for-credit) and $150 (no-credit). The 20.0 contact hours of ACPE credit are accepted for American Nurses Credentialing Center Certification Renewal. You can preview a segment of a curriculum module and speaker presentation. Read on to learn more about this great APNA offer and register now.

Registration

To access the APNA member rates, you must be logged into the web site. Log in or create a new account.

2012-2013 APNA Endorsed CPNP Psychiatric Pharmacotherapy Review CourseMembersNon-members
Psychiatric Pharmacotherapy Review Course - For Credit$320$480
Psychiatric Pharmacotherapy Review Course - No Credit$150$150

Download the printable registration form to register via mail or fax.

Accreditation (for-credit version only)

The College of Psychiatric and Neurologic Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. The 2012-2013 APNA Endorsed Psychiatric Pharmacotherapy Review Course is a knowledge-based course and will provide up to 20 contact hours (2.0 CEUs) of continuing education credit.

Statements of Credit (for-credit version only)

Registrants can obtain up to 20.0 contact hours of ACPE credit by successfully completing the CPNP Psychiatric Pharmacotherapy Review Course online examinations for each of the 14 topic areas included in the course. The course expires December 31, 2013.

ACPE Statements of Credit will be available online at cpnp.org upon successful completion of each examination for the 14 topic areas contained in the course. Successful completion is defined as achieving a score of 60% or higher on each examination. Notification of statement availability will be provided upon successful completion of the examination.

Lab for Reduced Haloperidol?

Our TX DSHS regional lab has informed us that, "no lab in the US can do reduced haloperidol concentrations anymore." Does anyone know of a lab that we can send our samples to? Stephen R. Saklad, Pharm.D., BCPP Clinical ...

Pharmacotherapy Handbook, Eighth Edition

Pharmacotherapy Handbook, Eighth Edition

Essential drug data in a concise, carry-anywhere reference

Pharmacotherapy Handbook, 8e provides practitioners and students with the critical information necessary to support drug therapy decision making for more than 140 diseases and disorders. Featuring a convenient alphabetized presentation, this handy guide utilizes tables, texts, figures, and treatment algorithms to make the information readily accessible and easily understood.

The author is a 2012 Meeting Speaker: Leadership Lessons Learned

Pharmacotherapy Principles and Practice, Second Edition

Pharmacotherapy Principles and Practice, Second Edition

Pharmacotherapy Principles and Practices utilizes a solid, evidence-based approach that supports the optimal pharmacotherapy of disease. In order to be as clinically relevant as possible, the disease states and treatments discussed focus on disorders most often seen in practice.

The author is a 2012 Meeting Speaker: Leadership Lessons Learned

Pharmacotherapy: A Pathophysiologic Approach, Eighth Edition (PHARMACOTHERAPY (DIPIRO))

Pharmacotherapy: A Pathophysiologic Approach, Eighth Edition (PHARMACOTHERAPY (DIPIRO))

Hailed by Doody's Review Service as "one of the best in pharmacy" Pharmacotherapy: A Pathophysiologic Approach is unmatched in its ability to help students develop a mastery of evidence-based medicine for optimum patient outcomes. The eighth edition will feature the addition of SI units throughout and an increased number of global examples and clinical questions.

The author is a 2012 Meeting Speaker: Leadership Lessons Learned

This page may contain content contributed by CPNP members or aggregated from other online sources. This content is provided as an unmoderated service to members for civil discussion and collaboration. Any opinions, conclusions, or recommendations are those of the author. If you come across any abuse or violation of the terms of use, please report the abuse.